Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma

It has been commonly found that in patients presenting Pancreatic Ductal Adenocarcinoma (PDAC), after a period of satisfactory response to standard treatments, the tumor becomes non-responsive and patient death quickly follows. This phenomenon is mainly due to the rapid and uncontrolled development...

Descripción completa

Detalles Bibliográficos
Autores principales: Molejon, Maria Inés, Tellechea, Juan Ignacio, Loncle, Celine, Gayet, Odile, Gilabert, Marine, Duconseil, Pauline, Lopez-Millan, Maria Belen, Moutardier, Vincent, Gasmi, Mohamed, Garcia, Stephane, Turrini, Olivier, Ouaissi, Mehdi, Poizat, Flora, Dusetti, Nelson, Iovanna, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480689/
https://www.ncbi.nlm.nih.gov/pubmed/25797268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480689/
https://www.ncbi.nlm.nih.gov/pubmed/25797268

Ejemplares similares